1-1 of 1
Trish Sweeney, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Trial of AT9283, a Multitargeted Kinase Inhibitor, in Patients with Refractory Hematological Malignancies.

Farhad Ravandi, MD, James Foran, MD, Srdan Verstovsek, MD, PhD, Jorge Cortes, MD, William Wierda, MD, PhD, Patricia Boone, Gautam Borthakur, Trish Sweeney, PhD, Hagop Kantarjian, MD
Journal: Blood
Blood (2007) 110 (11): 904.
https://doi.org/10.1182/blood.V110.11.904.904
Published: 2007